Advisor Group, Inc. - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M407. A total of 27 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q4 2019$0785
-15.0%
0.00%
Q3 2019$0
-100.0%
9230.0%0.00%
Q2 2019$1,0000.0%9230.0%0.00%
Q1 2019$1,0000.0%923
-4.2%
0.00%
Q4 2018$1,000
-50.0%
9630.0%0.00%
Q3 2018$2,000
+100.0%
963
+11.6%
0.00%
Q2 2018$1,0008630.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q4 2019
NameSharesValueWeighting ↓
CVI Holdings, LLC 156,655$266,0000.33%
Stonepine Capital Management, LLC 77,900$132,0000.08%
Anson Funds Management LP 54,450$93,0000.06%
SABBY MANAGEMENT, LLC 169,661$288,0000.04%
IMS Capital Management 24,916$42,0000.03%
Paulson Wealth Management Inc. 11,250$4,0000.00%
WEDBUSH SECURITIES INC 16,250$28,0000.00%
PEDDOCK CAPITAL ADVISORS, LLC 1$00.00%
UBS Group AG 1,813$3,0000.00%
MARINO, STRAM & ASSOCIATES LLC 2$00.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders